 |
PDBsum entry 1yxk
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Lipid binding protein
|
PDB id
|
|
|
|
1yxk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lipid binding protein
|
 |
|
Title:
|
 |
Crystal structure of human lectin-like oxidized low-density lipoprotein receptor 1 (lox-1) disulfide-linked dimer
|
|
Structure:
|
 |
Oxidised low density lipoprotein (lectin-like) receptor 1. Chain: a, b. Fragment: ligand-binding domain. Synonym: lox-1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.218
|
R-free:
|
0.277
|
|
|
Authors:
|
 |
I.Ohki,T.Ishigaki,T.Oyama,S.Matsunaga,Q.Xie,M.Ohnishi-Kameyama, T.Murata,D.Tsuchiya,S.Machida,K.Morikawa,S.Tate
|
Key ref:
|
 |
I.Ohki
et al.
(2005).
Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL.
Structure,
13,
905-917.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
22-Feb-05
|
Release date:
|
14-Jun-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P78380
(OLR1_HUMAN) -
Oxidized low-density lipoprotein receptor 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
273 a.a.
130 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
13:905-917
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL.
|
|
I.Ohki,
T.Ishigaki,
T.Oyama,
S.Matsunaga,
Q.Xie,
M.Ohnishi-Kameyama,
T.Murata,
D.Tsuchiya,
S.Machida,
K.Morikawa,
S.Tate.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Lectin-like, oxidized low-density lipoprotein (LDL) receptor 1, LOX-1, is the
major receptor for oxidized LDL (OxLDL) in endothelial cells. We have determined
the crystal structure of the ligand binding domain of LOX-1, with a short stalk
region connecting the domain to the membrane-spanning region, as a homodimer
linked by an interchain disulfide bond. In vivo assays with LOX-1 mutants
revealed that the "basic spine," consisting of linearly aligned
arginine residues spanning over the dimer surface, is responsible for ligand
binding. Single amino acid substitution in the dimer interface caused a severe
reduction in LOX-1 binding activity, suggesting that the correct dimer
arrangement is crucial for binding to OxLDL. Based on the LDL model structure,
possible binding modes of LOX-1 to OxLDL are proposed.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 5.
Figure 5. The Empty Cavity in the Dimer Interface of LOX-1
(A) Empty cavity located at the dimer interface in the
LOX-1 disulfide-lined dimer structure. The surrounding residues
of the cavity are shown as bold lines. (B) Possible effect
of the W150A mutation on the basic spine structure on the LOX-1
ligand recognition surface. The W150A mutation may resize the
empty cavity in the dimer interface, which subsequently
disarranges the dimer, resulting in the disruption of the basic
spine structure. The disrupted basic spine structure should lead
to severe reduction of the binding ability to ligands. (C)
A plausible representation of the entire structure of LOX-1 at
the cell surface, based on the crystal structure for CTLD and
the model structure for the NECK. Modeling was performed by
using the myosin heavy chain coiled-coil structure, which shows
a high level of sequence homology to the NECK region. (D)
Scale comparison between the the OxLDL particle and LOX-1 dimer.
The assembled structure of LOX-1 is drawn according to the
results of cell biology studies that showed LOX-1 to exist as a
hexamer on the cell surface (Xie et al., 2004). The diameter of
OxLDL was estimated from cryoelectron microscopic observation of
the LDL particle (Segrest et al., 2001). In this comparison, it
is assumed that no significant structural alterations are
induced by oxidation to the LDL particle.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2005,
13,
905-917)
copyright 2005.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Biocca,
M.Falconi,
I.Filesi,
F.Baldini,
L.Vecchione,
R.Mango,
F.Romeo,
G.Federici,
A.Desideri,
and
G.Novelli
(2009).
Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.
|
| |
PLoS ONE,
4,
e4648.
|
 |
|
|
|
|
 |
S.Iwamoto,
N.Nishimichi,
Y.Tateishi,
Y.Sato,
H.Horiuchi,
S.Furusawa,
T.Sawamura,
and
H.Matsuda
(2009).
Generation and characterization of chicken monoclonal antibodies against human LOX-1.
|
| |
MAbs,
1,
357-363.
|
 |
|
|
|
|
 |
W.Cao,
V.Calabro,
A.Root,
G.Yan,
K.Lam,
S.Olland,
J.Sanford,
A.Robak,
R.Zollner,
Z.Lu,
M.Ait-Zahra,
R.Agostinelli,
L.Tchistiakova,
D.Gill,
D.Harnish,
J.Paulsen,
and
H.H.Shih
(2009).
Oligomerization is required for the activity of recombinant soluble LOX-1.
|
| |
FEBS J,
276,
4909-4920.
|
 |
|
|
|
|
 |
E.Hooley,
E.Papagrigoriou,
A.Navdaev,
A.V.Pandey,
J.M.Clemetson,
K.J.Clemetson,
and
J.Emsley
(2008).
The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure.
|
| |
Biochemistry,
47,
7831-7837.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.W.Knowles,
T.L.Assimes,
E.Boerwinkle,
S.P.Fortmann,
A.Go,
M.L.Grove,
M.Hlatky,
C.Iribarren,
J.Li,
R.Myers,
N.Risch,
S.Sidney,
A.Southwick,
K.A.Volcik,
and
T.Quertermous
(2008).
Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD.
|
| |
BMC Med Genet,
9,
23.
|
 |
|
|
|
|
 |
N.S.Kar,
M.Z.Ashraf,
M.Valiyaveettil,
and
E.A.Podrez
(2008).
Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36.
|
| |
J Biol Chem,
283,
8765-8771.
|
 |
|
|
|
|
 |
A.A.Watson,
J.Brown,
K.Harlos,
J.A.Eble,
T.S.Walter,
and
C.A.O'Callaghan
(2007).
The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2.
|
| |
J Biol Chem,
282,
3165-3172.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Falconi,
S.Biocca,
G.Novelli,
and
A.Desideri
(2007).
Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant.
|
| |
BMC Struct Biol,
7,
73.
|
 |
|
|
|
|
 |
X.P.Chen,
T.T.Zhang,
and
G.H.Du
(2007).
Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
|
| |
Cardiovasc Drug Rev,
25,
146-161.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2006).
Survey of the year 2005 commercial optical biosensor literature.
|
| |
J Mol Recognit,
19,
478-534.
|
 |
|
|
|
|
 |
A.N.Zelensky,
and
J.E.Gready
(2005).
The C-type lectin-like domain superfamily.
|
| |
FEBS J,
272,
6179-6217.
|
 |
|
|
|
|
 |
T.Sawamura
(2005).
LOX-1 unlocked.
|
| |
Structure,
13,
834-835.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |